✦ LIBER ✦

Chronic daily administration of oral etoposide and cisplatin for advanced non-small cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of unresectable non-small cell

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Concomitant cisplatin, etoposide and rad

✍ Reboul, F.; Vincent, P.; Chauvet, B.; Brewer, Y.; Félix Faure, C.; Taulelle, M. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Oral etoposide preceding cisplatin in ad

✍ Focan, C.; Vandermoten, G.; Boossy, J.; Schallier, D. 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 571 KB

Taxol and cisplatin (TP) versus etoposid

✍ T.E. Ciuleanu; C. Cebotaru; I. Radulescu; N. Todor; N. Ghilezan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Gemcitabine and cisplatin for advanced n

✍ Casal, J.; Grande, C.; Caeiro, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Prolonged oral etoposide in combination

✍ Park, K; Kim, K; Jeong, HS; Lee, JT; Kim, WS; Yoon, SS; Kang, WK; Lee, HG; Kim, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 239 KB